IL17 genetic variants impact the response and safety of TNFi treatment in rheumatoid arthritis patients from Bahia, Brazil.
Lilian de Sá Garcia Landeiro, Pedro Augusto Silva Dos Santos Rodrigues, Almirane Lima de Oliveira, Katarina Mattos Brandão, Laryssa Cardoso Calmon, João Victor Andrade Cruz, Mailane Dos Anjos Silva, Bruna Ramos Tosta, Ingrid de Marins de Almeida, João Locke Ferreira de Araújo, Thamara Miranda Barbosa Dos Santos, Milca de Jesus Silva, Gabriela Pimentel Pinheiro das Chagas, Álvaro Augusto Souza da Cruz Filho, Camila Alexandrina Viana de Figueirêdo
Abstract
OBJECTIVE: Rheumatoid arthritis (RA) is a chronic inflammatory disease that can lead to progressive disability. TNF inhibitors (TNFi) have shown promise in improving disease progression and prognosis; however, only 60% to 70% of patients respond well…
Preview only. Read the full abstract at the source